Managing Nasal Ischemia and Necrosis Post‐Triamcinolone Injection: A New Case Series
Case Reports in Otolaryngology · 2026-01 · 2026 (1)
DOI: 10.1155/crot/2223358 ↗Kurz gefasst
Fachartikel in der Zeitschrift Case Reports in Otolaryngology, online erschienen am 03.07.2026. Verfasst von Shahriar Nazari und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of ENT and Head and Neck Surgery, BMI Hospital, Tehran, Iran. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Nasal ischemia following cosmetic injections has been reported in several cases. Postsurgery triamcinolone administration in the nasal region is a common practice to reduce inflammation and address pollybeak deformity. While cases of retinal artery occlusion following triamcinolone injection have been documented, this case series presents the first reported instance of nasal necrosis resulting from triamcinolone injection. This article explores the management strategies and therapeutic approaches for ischemia following triamcinolone administration. Four cases of nasal ischemia following triamcinolone injections administered postrhinoplasty are documented. The first case presented a young female who experienced ischemia with involvement of the columellar artery, leading to reduced blood flow in the dorsal and lateral nasal arteries. The remaining cases were patients who sought reconstructive surgery due to nasal necrosis caused by triamcinolone injections. Triamcinolone injection in the nasal region can lead to ischemia. Treatment options should be customized to each patient’s condition. The THIS and FAT protocol with toxins (botulinum neurotoxin), high‐dose hyaluronidase, and injectable platelet‐rich fibrin (iPRF), solid platelet‐rich fibrin (sPRF) dressings, and antibiotics as well as hyperbaric oxygen therapy (HBOT) can enhance tissue recovery, minimize scarring, and improve the overall outcome.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of ENT and Head and Neck Surgery, BMI Hospital, Tehran, Iran.
- Private Practice, Zibaban Clinic, Management and Research of Complications Clinic, Tehran, Iran.
- School of Medicine, Ahvaz Jondishapur University of Medical Sciences, Ahvaz, Iran.
- Department of Oral & Maxillofacial Surgery, College of Medicine, University of Florida, Jacksonville, Florida, USA, ufl.edu.
- Maxillogram Maxillofacial Surgery, Implantology and Biomaterial Research Foundation, Istanbul, Turkey.
- Department of Facial Plastic & Cranio-Maxillo-Facial Surgery, Fakih Hospital, Khaizaran, Lebanon.
ORCID-Profile: Shahriar Nazari, Mohammadamin Damsaz, Nabil Fakih-Gomez, Mohammad Reza Pourani
Zitieren
APA
Nazari, S., Hadadian, N., Bayatparidary, F., Keyhan, S. O., Damsaz, M., Fakih-Gomez, N., & Pourani, M. R. (2026). Managing Nasal Ischemia and Necrosis Post‐Triamcinolone Injection: A New Case Series. Case Reports in Otolaryngology, 2026(1). https://doi.org/10.1155/crot/2223358
Vancouver
Nazari S, Hadadian N, Bayatparidary F, Keyhan SO, Damsaz M, Fakih-Gomez N, et al. Managing Nasal Ischemia and Necrosis Post‐Triamcinolone Injection: A New Case Series. Case Reports in Otolaryngology. 2026;2026(1). doi:10.1155/crot/2223358
BibTeX
@article{Nazari2026,
author = {Nazari, Shahriar and Hadadian, Nima and Bayatparidary, Foroohe and Keyhan, Seied Omid and Damsaz, Mohammadamin and Fakih-Gomez, Nabil and Pourani, Mohammad Reza},
title = {Managing Nasal Ischemia and Necrosis Post‐Triamcinolone Injection: A New Case Series},
journal = {Case Reports in Otolaryngology},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/crot/2223358}
}
EUVIMED